Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid
- 31 October 2009
- journal article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 44 (10), 4169-4178
- https://doi.org/10.1016/j.ejmech.2009.05.009
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Susceptibility of Mycobacterium tuberculosis to isoniazid and its derivative, 1-isonicotinyl-2-nonanoyl hydrazine: investigation at cellular levelTuberculosis, 2003
- The mutant selection window and antimicrobial resistanceJournal of Antimicrobial Chemotherapy, 2003
- Effect of chloramphenicol, erythromycin, moxifloxacin, penicillin and tetracycline concentration on the recovery of resistant mutants of Mycobacterium smegmatis and Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 2003
- The type of isoniazid acetylation in tuberculosis patients treated at National Tuberculosis and Lung Diseases Research Institute.2003
- Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers.2003
- Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trialThe Lancet, 2002
- Isonicotinoylhydrazone analogs of isoniazid: relationship between superoxide scavenging and tuberculostatic activities.Biochemistry (Moscow), 2002
- Inhibition of InhA, the Enoyl Reductase from Mycobacterium tuberculosis, by Triclosan and IsoniazidBiochemistry, 2000
- High-Dose Isoniazid Therapy for Isoniazid-Resistant Murine Mycobacterium tuberculosis InfectionAntimicrobial Agents and Chemotherapy, 1999
- In-vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to amoxycillin and ticarcillin in combination with clavulanic acidJournal of Antimicrobial Chemotherapy, 1988